Tadaga Oral Jelly Flavoured 20mg Samok Overseas

£132.00

Tadaga Oral Jelly 20mg represents a flavoured tadalafil citrate formulation available in gel form. This Samok Overseas research compound enables convenient laboratory investigation of PDE5 inhibition mechanisms. Supplied in pre-measured sachets for precise analytical work.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Tadaga Oral Jelly Flavoured 20mg Samok Overseas
Tadaga Oral Jelly Flavoured 20mg Samok Overseas
£132.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: Tadaga Oral Jelly Flavoured

Tadaga Oral Jelly 20mg is a flavoured tadalafil citrate formulation manufactured by Samok Overseas, designed specifically for in-vitro laboratory research. This phosphodiesterase type 5 (PDE5) inhibitor is presented in a convenient oral jelly format, enabling researchers to investigate the pharmacological properties of tadalafil in various experimental protocols. The compound belongs to the same class as sildenafil but offers distinct pharmacokinetic characteristics that make it valuable for comparative studies. Researchers at Stroid UK Shop can access this formulation alongside comprehensive analytical documentation for their laboratory investigations.

Laboratory Applications

The oral jelly formulation presents unique research opportunities for studying absorption characteristics and bioavailability profiles in experimental models. Scientists examining PDE5 inhibition pathways can evaluate how the gel matrix affects compound release and dissolution rates compared to traditional tablet formulations. This research compound proves particularly valuable when investigating the relationship between formulation parameters and pharmacological activity. Researchers studying cardiovascular mechanisms can analyse how tadalafil’s selective PDE5 inhibition impacts nitric oxide signalling cascades in tissue samples. The flavoured gel format also enables studies into palatability factors and their influence on experimental compliance in animal models. Comparative research between this formulation and products available in our erection drugs category provides valuable insights into formulation science.

Technical Specifications

Tadaga Oral Jelly 20mg Research Specifications
Active Compound Tadalafil Citrate
Concentration 20mg per sachet
Formulation Flavoured oral jelly
Manufacturer Samok Overseas
Presentation Individual sachets
Storage Requirements Room temperature, dry conditions
Molecular Formula C₂₂H₁₉N₃O₄
CAS Number 171596-29-5

The gel matrix contains pharmaceutical excipients that maintain stability while ensuring consistent compound distribution. Each sachet provides precisely measured quantities suitable for analytical work. Researchers should store sachets in original packaging to prevent moisture exposure. This formulation enables direct analysis without requiring tablet dissolution procedures. Quality assurance documentation accompanies each batch for research verification purposes. Scientists investigating related compounds may also examine our SARMs collection and peptides range for comprehensive experimental design.

Research Compliance

This product is manufactured exclusively for in-vitro laboratory research and analytical applications. Not intended for human consumption, clinical use, or any application outside controlled laboratory environments. Researchers must ensure appropriate safety protocols and waste disposal procedures when handling this compound. All investigations should comply with institutional guidelines and applicable regulations governing research chemical use.

Related